(3,4-dichlorobenzyl)hydrazine hydrochloride, 95.0%, 500mg

2-(1H-Benzo[d]imidazol-2-yl)ethanamine hydrochloride, 95.0%, 5g

Methyl 2-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 100mg

MOCLOBEMIDE, 95%, 100mg

ETHYL 4-OXO-5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBOXYLATE, 95.0%, 2g

1-(Pyridin-4-ylmethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid, 1g

N-(2-Nitrophenyl)phosphoric TriaMide, 97%, 100mg

Métavanadate de potassium, min 97,5 %, pur, 50 g, emballage plastique.

(4S,5S)-1,3-Bis(2,6-dimethylphenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 98%, 250mg

2,5-Dioxopyrrolidin-1-yl 4-(1,2,2-triphenylvinyl)benzoate, 97%, 250mg

(benzylsulfanyl)methanimidamide hydrobromide, 95.0%, 10g

3-Hydroxypyridine 1-oxide, 95.0%, 100g

(6-Chloropyridazin-3-yl)(4-ethylpiperazin-1-yl)methanone, 98%, 1g